FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs
FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs
www.fda.gov
FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs
Today, the U.S. Food and Drug Administration is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded ...
